Eckert & Ziegler Strahlen- und Medizintechnik AG Logo

Eckert & Ziegler Strahlen- und Medizintechnik AG

Provider of isotope technology for cancer therapy, nuclear imaging, and industrial applications.

EUZ | F

Overview

Corporate Details

ISIN(s):
DE0005659700
LEI:
391200EUDABLUKXCKG48
Country:
Germany
Address:
Robert-Rössle-Str. 10, 13125 Berlin
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Eckert & Ziegler Strahlen- und Medizintechnik AG is a global provider of isotope technology and radioactive components for medical, scientific, and industrial applications. The company's core business activities focus on cancer therapy, industrial radiometry, and nuclear-medical imaging. Its product and service portfolio includes radiopharmaceuticals and chemicals, radiopharmaceutical development services, radiosynthesis and quality control solutions, and radiation therapy equipment. Additionally, the company offers specialized solutions such as hot cells and radiation protection systems, serving nuclear medicine institutions and industrial clients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 07:45
Earnings Release
Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth…
English 9.0 KB
2025-11-13 00:00
Regulatory News Service
Q3 statement / Q3 financial report 2025
English 1.7 MB
2025-11-11 14:14
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-11-07 12:12
Declaration of Voting Results & Voting Rights Announcements
English 15.9 KB
2025-11-06 10:13
Declaration of Voting Results & Voting Rights Announcements
English 15.9 KB
2025-10-20 13:57
Declaration of Voting Results & Voting Rights Announcements
English 16.0 KB
2025-09-19 12:00
Regulatory News Service
Eckert & Ziegler Gains Approval for GalliaPharm in Japan
English 7.5 KB
2025-09-09 11:30
Regulatory News Service
Eckert & Ziegler: Berenberg Starts Coverage with a Buy Recommendation and a Pri…
English 6.5 KB
2025-08-08 07:45
Earnings Release
Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
English 7.7 KB
2025-08-08 00:00
Interim Report
Half-yearly financial report 2025
English 3.3 MB
2025-08-05 11:50
Share Issue/Capital Change
Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to …
English 6.9 KB
2025-07-29 14:00
Regulatory News Service
Eckert & Ziegler Selected as US Manufacturer for Archeus Next-Generation Radiop…
English 7.4 KB
2025-07-28 13:37
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
English 4.5 KB
2025-07-15 14:00
Regulatory News Service
Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
English 7.4 KB
2025-06-18 16:05
Post-Annual General Meeting Information
Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
English 6.3 KB

Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eckert & Ziegler Strahlen- und Medizintechnik AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-30 Eckert, Dr. Andreas Supervisory board Sell None 1,526,400.00 EUR
2023-08-30 Eckert Wagniskapital und Frühphasenfinanzierung GmbH Close relation Buy None 1,526,400.00 EUR
2023-08-11 Perschmann, Frank Supervisory board Buy None 16,600.00 EUR
2023-01-13 NEON Equity AG Close relation Buy None 2,115.00 EUR
2023-01-12 Blunck, Dr. Thomas Board Sell None 57,402.00 EUR
2023-01-12 Blunck, Dr. Thomas Board Sell None 32,160.00 EUR
2023-01-11 Bouterfa, Dr. Hakim Board Buy None 124,800.00 EUR
2022-12-21 Eckert Wagniskapital und Frühphasenfinanzierung GmbH Close relation Buy None 1,432,800.00 EUR
2022-12-06 Maennig, Prof. Dr. Wolfgang Supervisory board Buy None 72,745.31 EUR
2022-12-05 Carpio GmbH Close relation Buy None 73,826.53 EUR

Peer Companies

Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland
AME
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America
DRTS
ANGIODYNAMICS INC Logo
Develops minimally invasive medical devices for vascular and oncology applications.
United States of America
ANGO
Apyx Medical Corp Logo
Develops helium plasma energy devices for cosmetic and surgical markets.
United States of America
APYX
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea
450950
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America
AMIX
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America
BDMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.